On Tuesday, Cassava Sciences reached an important technical milestone, seeing its Relative Strength (RS) Rating jump into the 90-plus percentile with an improvement to 92, up from 87 the previous trading day.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. This unique rating tracks technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains typically have an RS Rating of at least 80 in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
Cassava Sciences stock has recently cleared several key moving averages. Look for the stock to create a buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
Cassava Sciences showed 0% EPS growth last quarter, while sales growth came in at 0%.
Cassava Sciences earns the No. 276 rank among its peers in the Medical-Biomed/Biotech industry group. Amphastar Pharm, Immunogen and Alkermes are among the top 5 highly rated stocks within the group.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
